tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksChatGPT StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksTipRanks CommunityContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsSmart PortfolioExpert CenterTipRanksAI
TOOLS
My Portfolio
My Watchlist
Earnings Calendar
Stock Screener
Penny Stocks
Top Stocks
Daily Analyst Ratings
STOCKS
BABA
AAPL
SPY
AMZN
QQQ
TSLA
NVDA
ADVANCED RESEARCH
TipRanks Premium
Invest Like a Pro with Unique Data & Simplifed ToolsTry Now
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
ChatGPT Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
TipRanks Community
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

CPRX Stock Latest News

Catalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
Press ReleasesCatalyst Pharmaceuticals to Report First Quarter 2024 Financial Results on May 8, 2024
3d ago
CPRX
Catalyst Pharmaceuticals announces support for inaugural LEMS awareness day
PremiumThe Fly
Catalyst Pharmaceuticals announces support for inaugural LEMS awareness day
28d ago
CPRX
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
PremiumPress Releases
Catalyst Pharmaceuticals Announces Support for the Inaugural Lambert-Eaton Myasthenic Syndrome (LEMS) Awareness Day
28d ago
CPRX
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
PremiumPress Releases
Catalyst Pharmaceuticals to Participate in the 2024 Cantor Virtual Muscular Dystrophy Symposium
29d ago
CPRX
Catalyst Pharmaceuticals management to meet with Oppenheimer
PremiumThe Fly
Catalyst Pharmaceuticals management to meet with Oppenheimer
1M ago
CPRX
Catalyst Pharmaceuticals initiated with a Buy at Citi
PremiumThe FlyCatalyst Pharmaceuticals initiated with a Buy at Citi
1M ago
CPRX
Catalyst Pharmaceuticals management to meet with Oppenheimer
PremiumThe Fly
Catalyst Pharmaceuticals management to meet with Oppenheimer
1M ago
CPRX
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
PremiumPress Releases
Catalyst Pharmaceuticals Announces AGAMREE® Now Commercially Available in the U.S. for the Treatment of Duchenne Muscular Dystrophy (DMD)
1M ago
CPRX
Catalyst Pharmaceuticals announces commercial availability of AGAMREE
PremiumThe Fly
Catalyst Pharmaceuticals announces commercial availability of AGAMREE
1M ago
CPRX
‘Time to Hit Buy,’ Says Bank of America About These 3 Stocks
PremiumStock Analysis & Ideas
‘Time to Hit Buy,’ Says Bank of America About These 3 Stocks
1M ago
CPRX
SBAC
BofA starts ‘unique aggregator’ Catalyst Pharmaceuticals with a Buy
PremiumThe Fly
BofA starts ‘unique aggregator’ Catalyst Pharmaceuticals with a Buy
2M ago
CPRX
Catalyst Pharmaceuticals initiated with a Buy at BofA
PremiumThe Fly
Catalyst Pharmaceuticals initiated with a Buy at BofA
2M ago
CPRX
Catalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
PremiumPress ReleasesCatalyst Pharmaceuticals to Participate at the Barclays 26th Annual Global Healthcare Conference
2M ago
CPRX
Catalyst Pharmaceuticals sees FY24 revenue $455M-$475M, consensus $463.19M
PremiumThe Fly
Catalyst Pharmaceuticals sees FY24 revenue $455M-$475M, consensus $463.19M
2M ago
CPRX
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
PremiumPress Releases
Catalyst Pharmaceuticals Reports Strong Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2M ago
CPRX
Catalyst Pharmaceuticals reports Q4 adjusted EPS 56c, consensus 26c
PremiumThe Fly
Catalyst Pharmaceuticals reports Q4 adjusted EPS 56c, consensus 26c
2M ago
CPRX
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
PremiumPress Releases
Catalyst Pharmaceuticals to Present at MDA Clinical & Scientific Conference Details of Registry for Study of Long-Term Safety and Quality of Life in Duchenne Muscular Dystrophy Patients Treated with AGAMREE
2M ago
CPRX
Is CPRX a Buy, Before Earnings?
PremiumPre-Earnings
Is CPRX a Buy, Before Earnings?
2M ago
CPRX
Catalyst Pharma Announces Promising Duchenne Drug Study Results
PremiumCompany Announcements
Catalyst Pharma Announces Promising Duchenne Drug Study Results
2M ago
8K
CPRX
Catalyst announces publication of Santhera’s VISION-DMD study results
PremiumThe FlyCatalyst announces publication of Santhera’s VISION-DMD study results
2M ago
CPRX
Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology
PremiumPress Releases
Catalyst Pharmaceuticals Announces Publication of Santhera Pharmaceutical’s VISION-DMD Vamorolone (AGAMREE®) Study Results in the Peer-Reviewed Journal Neurology
2M ago
CPRX
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
PremiumPress Releases
Catalyst Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
2M ago
CPRX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >